BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
TargeGen closes on $40 million venture round
News | 07. 12. 2007
TargeGen
TargeGen, Inc. has announced that the Company has successfully closed a $40M venture round of financing.
